Filing Flows › Myriad Genetics (MYGN) › Mental Health revenue
Myriad Genetics (MYGN) Mental Health revenue by quarter
Myriad Genetics' Mental Health revenue was $39.5M in Q3 2026 (third quarter 2026), +7% from Q2 2026. Over the last 3 quarters it ranged from $36.8M (Q2 2026) to $39.5M (Q3 2026).
| Quarter | Mental Health revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $39.5M | +7% | — |
| Q2 2026 | $36.8M | -4% | — |
| Q1 2026 | $38.3M | — | — |
Q3 2026 at a glance
Myriad Genetics, Q3 2026: revenue $203M (-2% year over year), operating margin -19.7%, net loss $43.9M, operating cash flow −$6.5M. The chart follows the revenue to costs, profit and cash.
Questions
What is Myriad Genetics' Mental Health revenue?
Myriad Genetics' Mental Health revenue was $39.5M in Q3 2026 (third quarter 2026), +7% from Q2 2026.
How has Myriad Genetics' Mental Health revenue changed?
Over the last 3 quarters it ranged from $36.8M (Q2 2026) to $39.5M (Q3 2026).